Lv71
4430 积分 2020-12-28 加入
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
14天前
已完结
Trends in the drug target landscape for autoimmune diseases
4个月前
已完结
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
2年前
已完结
First-in-class versus best-in-class: an update for new market dynamics
2年前
已完结
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
2年前
已完结
Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose
2年前
已完结
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
2年前
已完结
皖公网安备34019202002308
